Literature DB >> 15155720

Structural basis for the catalytic activity of human serine/threonine protein phosphatase-5.

Mark R Swingle1, Richard E Honkanen, Ewa M Ciszak.   

Abstract

Serine/threonine protein phosphatase-5 (PP5) affects many signaling networks that regulate cell growth and cellular responses to stress. Here we report the crystal structure of the PP5 catalytic domain (PP5c) at a resolution of 1.6 A. From this structure we propose a mechanism for PP5-mediated hydrolysis of phosphoprotein substrates, which requires the precise positioning of two metal ions within a conserved Asp271-M1:M2-W1-His427-His304-Asp274 catalytic motif (where M1 and M2 are metals and W1 is a water molecule). The structure of PP5c provides a structural basis for explaining the exceptional catalytic proficiency of protein phosphatases, which are among the most powerful known catalysts. Resolution of the entire C terminus revealed a novel subdomain, and the structure of the PP5c should also aid development of type-specific inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155720     DOI: 10.1074/jbc.M402855200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

Review 1.  Protein phosphatases in pancreatic islets.

Authors:  Henrik Ortsäter; Nina Grankvist; Richard E Honkanen; Åke Sjöholm
Journal:  J Endocrinol       Date:  2014-03-28       Impact factor: 4.286

2.  Cytokines alter glucocorticoid receptor phosphorylation in airway cells: role of phosphatases.

Authors:  Belaid Bouazza; Kateryna Krytska; Manel Debba-Pavard; Yassine Amrani; Richard E Honkanen; Jennifer Tran; Omar Tliba
Journal:  Am J Respir Cell Mol Biol       Date:  2012-05-16       Impact factor: 6.914

Review 3.  Targeting protein serine/threonine phosphatases for drug development.

Authors:  Jamie L McConnell; Brian E Wadzinski
Journal:  Mol Pharmacol       Date:  2009-03-19       Impact factor: 4.436

4.  Total synthesis and evaluation of cytostatin, its C10-C11 diastereomers, and additional key analogues: impact on PP2A inhibition.

Authors:  Brian G Lawhorn; Sobhana B Boga; Scott E Wolkenberg; David A Colby; Carla-Maria Gauss; Mark R Swingle; Lauren Amable; Richard E Honkanen; Dale L Boger
Journal:  J Am Chem Soc       Date:  2006-12-27       Impact factor: 15.419

5.  The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.

Authors:  Brandon M D'Arcy; Mark R Swingle; Cinta M Papke; Kevin A Abney; Erin S Bouska; Aishwarya Prakash; Richard E Honkanen
Journal:  Mol Cancer Ther       Date:  2019-01-24       Impact factor: 6.261

6.  Deprotonation states of the two active site water molecules regulate the binding of protein phosphatase 5 with its substrate: A molecular dynamics study.

Authors:  Lingyun Wang; Feng Yan
Journal:  Protein Sci       Date:  2017-07-28       Impact factor: 6.725

7.  Molecular basis for TPR domain-mediated regulation of protein phosphatase 5.

Authors:  Jing Yang; S Mark Roe; Matthew J Cliff; Mark A Williams; John E Ladbury; Patricia T W Cohen; David Barford
Journal:  EMBO J       Date:  2004-12-02       Impact factor: 11.598

8.  Interactions of cantharidin-like inhibitors with human protein phosphatase-5 in a Mg2+ system: molecular dynamics and quantum calculations.

Authors:  Letícia C Assis; Alexandre A de Castro; Ingrid G Prandi; Daiana T Mancini; Juliana O S de Giacoppo; Ranylson M L Savedra; Tamiris M de Assis; Juliano B Carregal; Elaine F F da Cunha; Teodorico Castro Ramalho
Journal:  J Mol Model       Date:  2018-10-02       Impact factor: 1.810

9.  Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer.

Authors:  Teresa Golden; Ileana V Aragon; Beth Rutland; J Allan Tucker; Lalita A Shevde; Rajeev S Samant; Guofei Zhou; Lauren Amable; Danalea Skarra; Richard E Honkanen
Journal:  Biochim Biophys Acta       Date:  2008-01-26

Review 10.  Protein phosphatase 5.

Authors:  Terry D Hinds; Edwin R Sánchez
Journal:  Int J Biochem Cell Biol       Date:  2007-08-30       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.